MyoTrace Continuous Monitoring Scenario

The integration of EMG sensors to measure neural respiratory drive in a non-invasive system addresses the limitation of breathing rate alone, offering a more accurate assessment of respiratory effort and improving early warning scoring in hospital wards.

JP2024544780AInactive Publication Date: 2024-12-04KONINKLIJKE PHILIPS NV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024535453
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-17
Filing Date
2022-12-05
Publication Date
2024-12-04
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing non-invasive respiratory monitoring systems in hospital wards lack the ability to objectively quantify the effort a patient exerts while breathing, as breathing rate alone does not provide insight into respiratory health, especially for conditions like COPD.

Method used

A non-invasive system using EMG sensors to measure neural respiratory drive (NRD) by monitoring upper thoracic inspiratory muscles during normal and effortful nasal inhalation, integrated with other metrics like heart rate and SpO2, to provide a more accurate assessment of respiratory status.

Benefits of technology

The system provides a more accurate representation of respiratory effort, enhancing early warning scoring by improving the detection of adverse respiratory conditions and reducing the risk of missed diagnoses.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024544780000001_ABST
    Figure 2024544780000001_ABST
Patent Text Reader

Abstract

In addition to other patient metrics that are typically monitored non-invasively, a non-invasive system for monitoring neural respiratory drive (NRD) utilizes continuous parasternal EMG signal measurements. The system can be integrated into an early warning scoring (EWS) system used to perform spot checks on patients in general hospital wards. Using a pulmonologist's judgment as the gold standard for determining respiratory status, the disclosed system determines a patient's respiratory status significantly more accurately than EWS systems that use parameters such as respiratory rate alone, because the NRD assessment provides an objective quantification of the effort it takes for a patient to breathe. In particular, the NRD assessment system takes EMG measurements of the upper thoracic inspiratory muscles during either or both normal inhalation and effortful nasal inhalation. This is because EMG measurements taken during inhalation are considered to be an indicator of the balance between respiratory muscle load and respiratory muscle capacity.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001]

[01] The disclosed concepts relate to methods and systems for continuous monitoring of a patient's respiratory condition, and in particular to methods and systems for improving wearable devices for continuous, non-invasive monitoring of a patient's respiratory status and other metrics. [Background technology]

[0002]

[02] Early warning scoring (EWS) systems for detecting deterioration and tracking trends in a patient's health status are often used in non-acute medical settings such as general wards in hospitals. FIG. 1 shows a diagnostic chart 1 listing some exemplary parameters monitored in a typical implementation of an EWS system. As shown in FIG. 1, heart rate, systolic blood pressure, respiratory rate, SpO2, body temperature, and level of consciousness are non-limiting representative examples of non-invasive physiological parameters that are often used to monitor a patient's condition in a general ward in a hospital. These parameters may be monitored continuously, for example, through the use of a wearable patch structured to be attached to the patient's skin via an adhesive backing. Although factors other than those listed in the diagnostic chart 1 may be monitored with an EWS system, those shown in FIG. 1 are representative of a combination of factors typically used to diagnose and monitor a patient's overall condition in a general ward. Some factors listed in the diagnostic chart 1 are weighted differently than other factors. For example, if a slightly low body temperature, a slightly low SpO2, or a slightly low respiration rate is detected, the patient may only require monitoring without immediate drastic action, whereas if the systolic blood pressure is too low, more definitive action may be taken immediately.

[0003]

[03] With regard to adverse respiratory conditions, accurate detection of patient respiratory effort in general wards is important because one in six general ward patients is at three times higher risk of developing an adverse respiratory event than if they were not in a general ward. Because respiratory rate can be easily measured non-invasively, respiratory rate is often monitored in EWS systems. However, while non-invasive measurement of respiratory rate is useful, respiratory rate alone does not provide a complete picture of respiratory health because it does not provide insight into the effort made by the patient while breathing. For example, if a relatively healthy person and a person with chronic obstructive pulmonary disease (COPD) exhibit the same respiratory rate, the person with COPD will have to make significantly more effort to breathe at the same rate as the healthy person. Respiratory rate alone does not provide insight into how much effort each person was making to breathe at that rate. Summary of the Invention [Problem to be solved by the invention]

[0004]

[04] Thus, there is room for improvement in the methods and systems used to non-invasively monitor the respiratory condition of patients in general hospital wards, along with other patient metrics that are typically measured non-invasively.

[0005]

[05] It is therefore an object of the present invention to provide a non-invasive system and method for objectively quantifying the patient's effort while breathing, called Neural Respiratory Drive (NRD), in combination with other metrics that are typically measured non-invasively. The NRD measurable monitoring system and method disclosed herein provides for monitoring of parasternal EMG signals, which can be integrated into an Early Warning Scoring (EWS) system used to perform spot checks of patient health in general hospital wards. In particular, the NRD assessment system takes EMG measurements of the upper thoracic inspiratory muscles during either or both normal inhalation and effortful nasal inhalation. This is because EMG measurements taken during inhalation are considered to be an indicator of the balance between respiratory muscle load and respiratory muscle capacity. [Means for solving the problem]

[0006] In one embodiment, a non-invasive patient monitoring system for non-invasively monitoring a patient's respiratory status and at least one other non-respiratory metric of the patient includes a sensor patch including a plurality of EMG electrodes and a number of non-EMG sensors structured to be affixed to the patient's upper chest, a controller electrically connected to the EMG electrodes, and a user interface in electrical communication with the controller. The controller is configured to determine a neural respiratory drive index based on EMG signal data sensed by the EMG electrodes during at least one of a normal breathing act and a nasal inhalation act.

[0007]

[07] In another embodiment, a method for non-invasively monitoring a patient's neural respiratory drive and other non-respiratory metrics includes positioning a sensor patch with a plurality of EMG electrodes and a number of non-EMG sensors on the patient's upper chest, electrically connecting the sensor patch to a controller, electrically connecting the controller to a user interface, sensing EMG signal data with the plurality of EMG electrodes during an inhalation performed by the patient, and determining a neural respiratory drive index with the controller based on a number of attributes of the inhalation. The inhalation includes at least one of a normal breath or an inhalation through the nose. Electrically connecting the sensor patch to the controller electrically connects the plurality of EMG electrodes and the number of non-EMG sensors to the controller.

[0008] In another embodiment, a non-invasive patient monitoring system for non-invasively monitoring a patient's respiratory status and at least one other non-respiratory metric of the patient includes a sensor patch structured to be affixed to the skin of the patient's upper thorax and a user interface. The sensor patch includes a plurality of EMG electrodes, a number of non-EMG sensors, and a controller electrically connected to the sensor patch. The user interface is in electrical communication with the controller, and the controller is configured to determine a neural respiratory drive index based on EMG signal data sensed by the EMG electrodes during at least one of a normal breathing act and a nasal inhalation act.

[0009]

[09] These and other objects, features, and characteristics of the present invention, as well as the method and function of operation of the associated elements of structure, combination of parts, and economies of manufacture, will become more apparent upon consideration of the following description and appended claims, taken in conjunction with the accompanying drawings, all of which form a part of this specification, in which like reference numerals represent corresponding parts in the various views. It is to be expressly understood, however, that the drawings are for the purpose of illustration and description only, and are not intended as a definition of the limits of the invention. [Brief description of the drawings]

[0010] [Figure 1]

[10] This is a diagnostic chart listing parameters typically included in Early Warning Scoring (EWS) systems used to monitor patient status in non-urgent patient situations. [Diagram 2]

[11] FIG. 1 illustrates a system for non-invasively determining a patient's neural respiratory drive (NRD) in combination with other metrics that are typically measured non-invasively, in accordance with an exemplary embodiment of the present invention. [Diagram 3]

[12] FIG. 1 is a flowchart of a method for non-invasively monitoring a patient's NRD, according to an exemplary embodiment of the present invention. [Figure 4]

[13] FIG. 3 illustrates a receiver operating characteristic (ROC) curve representing the accuracy of determining a patient's respiratory status by the controller shown in FIG. 2 in accordance with an exemplary embodiment of the present invention. [Diagram 5]

[14] A diagram showing a receiver operating characteristic (ROC) curve that represents the accuracy of the controller's determination of the patient's respiratory status using parameters typically included in early warning systems in non-urgent patient situations, such as the parameters included in the diagnostic chart shown in Figure 1. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0011]

[15] As used herein, the singular forms "a," "the," and "the" include plural references unless the context clearly dictates otherwise.

[0012]

[16] As used herein, the statement that two or more parts or components are “coupled” means that, to the extent a connection exists, the parts connect or operate together either directly or indirectly, i.e., through one or more intermediate parts or components.

[0013]

[17] As used herein, the term "controller" refers to any programmable analog and / or digital device (including associated memory components or memory sections) capable of storing, retrieving, executing, and processing data (e.g., software routines and / or information used by such routines). These devices include, but are not limited to, field programmable gate arrays (FPGAs), complex programmable logic devices (CPLDs), programmable systems on chips (PSOCs), application specific integrated circuits (ASICs), microprocessors, microcontrollers, programmable logic controllers, or any other suitable processing devices or apparatus. The memory sections may be any one or more of various types of internal and / or external storage media, such as, but not limited to, RAM, ROM, EPROM, EEPROM, FLASH, and others. These provide storage registers, i.e., non-transitory machine-readable media, for storage of data and program code, such as in the manner of a computer's internal storage area, and may be volatile or non-volatile memory.

[0014]

[18] As used herein, the term "number" means one or an integer greater than one (i.e., a plurality).

[0015]

[19] As used herein, directional terms such as, by way of example and not limitation, top, bottom, left, right, superior, lower, front, rear, and derivatives thereof, relate to the orientation of the elements illustrated in the drawings and do not constitute limitations on the claims, unless expressly stated herein.

[0016]

[20] As described in more detail herein in connection with various specific exemplary embodiments, the present invention provides a method and system for determining a patient's effort to breathe in a non-invasive manner and in combination with other metrics that are typically measured non-invasively. The disclosed method accurately determines whether a patient is experiencing an adverse respiratory condition and determines, among other things, the patient's neurological respiratory drive (NRD) in addition to vital signs that are typically measured as part of an Early Warning Scoring (EWS) system used for both spot checks and continuous monitoring of a patient's health status in general hospital wards. The NRD provides a more accurate representation of a patient's respiratory status than other non-invasive parameters used to determine a patient's respiratory status. Other non-invasive parameters include respiration rate alone or considered in combination with other non-invasive measurements such as those listed in diagnostic chart 1 shown in FIG. 1. In contrast to respiration rate, which does not provide an indication of the patient's effort to breathe at a constant rate, the NRD provides an objective measurement of the effort to breathe. It should be noted that while methods and systems for invasively determining NRD are known, the methods and systems disclosed herein are non-invasive and utilize EMG sensors worn on the skin. In particular, the methods and systems disclosed herein use EMG measurements of the upper thoracic inspiratory muscles to determine NRD, as EMG measurements taken during inhalation are believed to indicate the balance between respiratory muscle load and capacity.

[0017]

[21] Referring now to FIG. 2, a non-invasive patient monitoring system 10 with NRD monitoring capabilities is shown in accordance with an exemplary embodiment of the present invention. The monitoring system 10 includes a sensor patch 12 with a number of EMG signal electrodes 14 and a reference electrode 16, a controller 18, and a user interface 20. The sensor patch 12 is structured to be attached to the skin of a patient P via an adhesive surface, by way of example and not limitation. In an exemplary embodiment, the sensor patch 12 is positioned such that the signal electrode 14 is located in the second intercostal space and the reference electrode 16 is placed slightly higher on the sternum than the reference electrode 14 (relative to the representation shown in FIG. 2) to optimally monitor respiratory muscle activity of the patient P. However, it will be recognized that placement of the signal electrode 14 and the reference electrode 16 at other locations within the upper chest are desired and may be implemented without departing from the scope of the disclosed concept. The EMG signals sensed by the electrodes 14, 16 are subsequently used to determine an NRD index, as disclosed later herein with respect to a method 100 depicted in FIG. 3.

[0018]

[22] The controller 18 is configured to electrically communicate with the electrodes of the sensor patch 12 and the user interface 20. This allows the controller 18 to receive and store signals measured by the EMG electrodes 14, 16, and allows a clinician, caregiver, or even the patient P to input commands to the controller 18 as well as receive results of any processing performed by the controller 18 via the user interface 20 (as described in further detail herein). The sensor patch 12 is configured to non-invasively monitor a combination of metrics, i.e., NRD and at least one other metric, where the at least one other metric may include, by way of example and not limitation, one of the metrics listed under the "Score" column in FIG. 1. Accordingly, the sensor patch 12 includes an additional sensor 22 that is not reached by the EMG electrodes 14, 16. The additional sensor 22 may include, by way of example and not limitation, an accelerometer, a chest SpO2 sensor, or a core body temperature sensor. Exemplary uses of these optional sensors 22 are detailed further below herein with respect to the details of how the NRD monitoring system 10 can operate in various continuous and triggered modes of operation. It should be noted that while the representation of the additional sensor 22 in FIG. 2 gives the impression that the additional sensor 22 is external to the sensor patch 12, the representation of the additional sensor 22 in FIG. 2 is for purposes of clarity and clarity that the sensor patch 12 includes additional sensors that are not reached by the electrodes 14, 16, and that the additional sensor 22 is integrated within the sensor patch 12.

[0019]

[23] Although FIG. 2 depicts the connections of the EMG electrodes 14, 16 to the controller 18, and the controller 18 to the user interface 20, it should be noted that these connections are shown solely to depict electrical communications between the electrodes 14, 16 and the controller 18, and between the controller 18 and the user interface 20, and these communications may be facilitated via either wired or wireless communication means without departing from the scope of the disclosed concepts. In some exemplary embodiments, the sensor patch 12 may be a passive patch capable of taking measurements only when external power is provided to the patch. In other exemplary embodiments, the sensor patch 12 may be an active patch with an on-board power source and processing means. In one non-limiting exemplary implementation of the sensor patch 12 as an active patch, the controller 18 is integrated into the sensor patch 12, such that the on-board power source and processing means described above are provided by the controller 18.

[0020]

[24] With regard to communication between the controller 18 and the user interface 20, it should be noted that although the controller 18 and the user interface 20 are depicted as two separate entities in FIG. 2, in some exemplary embodiments, the user interface 20 is integrated into the same physical structure as the controller 18, while in other exemplary embodiments, the controller 18 and the user interface 20 reside in separate structures. By way of example and not limitation, in a hospital setting, the user interface 20 may include a patient monitor, while in an embodiment of the NRD monitoring system 10 implemented for home use, the user interface 20 may include the patient's personal mobile phone. It will be appreciated that the controller 18, whether implemented on-board the sensor patch 12 or external to the sensor patch 12, may be optionally configured to couple data sensed by the sensor patch 12 to a computing cloud 24.

[0021]

[25] Referring now to Figure 3, a flow chart of a method 100 for non-invasively monitoring a patient's NRD in accordance with an exemplary embodiment of the disclosed concepts is shown. The method of Figure 3 may be performed, for example, by the NRD monitoring system 10 shown in Figure 2, and the method will be described in conjunction with the NRD monitoring system 10. However, it will be appreciated that the method may also be employed in other devices without departing from the scope of the disclosed concepts.

[0022]

[26] In step 101, the sensor patch 12 is positioned on the patient P as shown in FIG. 2 or as otherwise desired to measure the patient P's respiratory muscle activity. When using an implementation of the NRD monitoring system 10 in which the controller 18 is not implemented on-board the sensor patch 12, wires are also connected between the sensor patch 12 and the controller 18 during step 101. It will be appreciated that the controller 18 is configured to electrically communicate with the user interface 20 without additional setup from the user. It will also be appreciated that the patient P's skin needs to be prepared to optimize sensing of the EMG signal. For example, the skin needs to be cleaned and / or shaved.

[0023]

[27] At step 102, an operating mode of the controller 18 is selected. As will be described in further detail later herein with respect to FIG. 4, in an exemplary embodiment, the controller 18 can operate in either a triggered mode or a continuous mode. At step 103, EMG signals produced by the patient P during either or both of breathing normally and inhaling through the nose are sensed by the sensor patch 12. The decision of whether to use only breathing normally or only inhaling through the nose, or both, to determine NRD is described in further detail herein with respect to FIG. 4. In an exemplary embodiment of the disclosed concept, the patient P breathes normally for one minute, followed by one minute of inhaling through the nose interspersed with breathing normally. Inhaling through the nose is defined as a deep, sharp inhalation that the patient P perceives as requiring a strong inhalation effort.

[0024]

[28] In step 104, an NRD index is determined based on some attributes of the normal breathing EMG signal and / or the nasal breathing EMG signal detected in step 102. The NRD index is a quantification of NRD based on various attributes of the EMG signal recorded during either or both of the normal breathing and nasal breathing actions performed by the patient P. Possible attributes of the normal breathing EMG signal and the nasal breathing EMG signal that may be used to determine the NRD index are detailed further herein with respect to FIG. 4. In step 105, the condition of the patient P is determined based on the calculated NRD index, taking into account other parameters included in the EWS system, if desired. By way of example and not limitation, depending on the reason for monitoring the patient, the respiratory condition of the patient P may be determined based on the determined NRD index alone, while the overall condition of the patient may be determined using all factors in the EWS system, or only a subset of factors in the EWS system 1.

[0025]

[29] Referring now to Figures 4 and 5, two different sets of receiver operating characteristic (ROC) curves are shown. Figure 4 shows a set of ROC curves representing respiratory status determinations by a controller that calculates the NRD index, such as controller 18 in NRD monitoring system 10 (Figure 2), and Figure 5 shows a set of ROC curves representing respiratory status determinations by a controller using the conventional EWS system parameters shown in Diagnostic Chart 1 (Figure 1). For the data shown in both Figures 4 and 5, a pulmonologist's determination of the patient's respiratory status was used as the gold standard against which the controller's determinations were compared. The sensitivity and specificity of the data contained in the curves were determined by comparing the controller's determinations to the pulmonologist's determinations.

[0026]

[30] In the description of Figures 4 and 5, the term #Samples refers to the number of data points used to generate each ROC curve, i.e., the number of times the patient's respiratory status was determined. For example, if the ROC curve is generated based on data collected for one patient whose respiratory status was checked twice a day for 10 days, the number of samples is equal to 20, whereas if the ROC curve is generated based on data collected for five patients whose respiratory status was checked twice a day for 15 days, the number of samples is equal to 150. The term #N indicates the number of times the patient's respiratory status has worsened compared to the status check immediately preceding the current status check, and the term #P indicates the number of times the patient's respiratory status has improved compared to the status check immediately preceding the current status check. The data presented in the ROC curves shown in Figures 4 and 5 represent the number of times the controller correctly determined (correctness is relative to the pulmonologist's judgment) whether the patient's respiratory status has worsened or improved since the previous status check. It will be appreciated that assessment of deterioration and improvement can be used, by way of example and not limitation, to assess whether a patient is responding well to a course of therapy / treatment or whether the patient is likely to be discharged from the hospital.

[0027]

[31] It is easily apparent from Figs. 4 and 5 that the reasonable operating points of the curves shown in Fig. 4 (one of which is labeled in Fig. 4) are predominantly distributed near the upper left corner of the graph compared to the curves shown in Fig. 5. This shows that the NRD determination by the system 10 in Fig. 2 has a significantly higher rate of sensitivity and specificity compared to the respiratory status determination using the parameters shown in the diagnostic chart 1 in Fig. 1. In particular, when considering the areas under the curves (denoted as AUC in the legends of Figs. 4 and 5) of all the ROC curves, the curves in Fig. 4 show a significantly higher overall AUC value, since the ROC curve in Fig. 5 with the highest AUC has an AUC of 0.54, while the ROC curve in Fig. 4 with the highest AUC shows a significantly larger AUC value ranging from 0.74 to 0.83. Because pulmonologists, in thoroughly evaluating a respiratory patient, will order and review x-rays of the patient's respiratory system, measure the FEV1, and / or take into account the patient's medical history when determining the patient's respiratory status, it will be recognized that it is noteworthy that an automated, non-invasive method and system for assessing respiratory status is capable of producing a ROC curve with an AUC of 0.83 for a sample set of 125 (i.e., the methodology that yielded the data used to generate ROC curve 30 of FIG. 4).

[0028]

[32] In Figure 4, each ROC curve corresponds to a different set of attributes of the normal breathing EMG signal and / or the nasal inhalation EMG signal that are used to calculate the NRD index relative to the other ROC curves. In Figure 5, the differences in the ROC curves represent the different weights given to each factor included in Diagnostic Chart 1 in Figure 1. Curve 30 in Figure 4 represents the most accurate method for calculating the NRD index, as the data points in curve 30 demonstrate the highest overall sensitivity and specificity, including an AUC of 0.83. Curve 30 reflects the calculation of the NRD index by recording the EMG signal while the patient breathes normally for one minute, recording the EMG while the patient breathes in through the nose for one minute (as described above in relation to method 100 of FIG. 3, breathing in through the nose is defined as a deep, sharp inhale that the patient P perceives as requiring a hard inhalation effort), finding the maximum signal value from the peak of the inhalation portion of the normal breathing EMG signal, finding the maximum signal value in the nose breathing EMG signal, and finding the ratio of the maximum normal breathing EMG signal value to the maximum nose breathing EMG signal value.

[0029]

[33] As used hereafter, the term "relative" refers to using attributes of both the normal breathing EMG signal and the nasal breathing EMG signal to calculate the NRD index when it pertains to determining the NRD index. Correspondingly, as used hereafter, the term "absolute" refers to using attributes of only one of the normal breathing EMG signal or the nasal breathing EMG signal, but not both, when it pertains to determining the NRD index. It should be noted that in most cases where the absolute NRD index is calculated, attributes of the normal breathing EMG signal are used rather than attributes of the nasal breathing EMG signal, but this is not a requirement.

[0030]

[34] For the ROC curves shown in FIG. 4 other than curve 30, non-limiting examples of methods used to calculate the NRD index include evaluating only the maximum value of the peak in the EMG signal of breathing through the nose and evaluating only the duration of the inhalation peak in the EMG signal of normal breathing. Although a relative NRD index calculated by comparing normal breathing with breathing through the nose has been found to more closely match a pulmonologist's opinion of a worsening or improving respiratory condition more frequently than an absolute NRD measure based only on normal breathing or only on breathing through the nose, it should be noted that there are circumstances in which an absolute measure of NRD based only on normal breathing (or only on breathing through the nose) is preferred. For example, because breathing through the nose is a strenuous maneuver, clinicians must guide or motivate patients to breathe through the nose sufficiently, and seriously ill patients are often unable to breathe through the nose. In addition, breathing through the nose is difficult to perform reproducibly.

[0031]

[35] With continued reference to FIG. 4, we consider both the high accuracy of the relative NRD determination using both normal breathing and nasal breathing EMG data, as well as some of the above-mentioned limitations presented by using nasal breathing EMG data to determine NRD. It will be recognized that in some contexts, a relative NRD determination is preferred, while in other contexts, an absolute determination using only normal breathing data (or only nasal breathing data) is preferred. Accordingly, it should be noted that the exemplary embodiment of the NRD monitoring system 10 can be operated in at least two modes, where at least one mode is a trigger mode and another mode is a continuous mode, as previously described with respect to step 102 of method 100 (FIG. 3). The triggered and continuous modes are described in further detail below in this specification, but as a preliminary matter it should be noted that the triggered mode calculation of the NRD index generally produces a relative NRD index based on EMG signal data from both normal breathing and nasal inhalation, whereas the continuous mode calculation of the NRD index generally produces an absolute NRD index based only on EMG signal data from normal breathing.

[0032]

[36] In the trigger mode, the controller 18 only calculates the NRD index for the patient P when a trigger condition occurs. Three non-limiting examples of triggers that can prompt the controller 18 to calculate the NRD index include (1) patient condition, (2) time since previous measurement, and (3) acquired vitals. The patient condition trigger may include a manual trigger where the controller 18 determines the NRD of the patient P when, by way of example and not limitation, a caregiver or the patient P provides an input to the user interface 20 that the patient P is not feeling well or that the patient P's circumstances have changed (e.g., the patient P is moving to a different medical department). The time since previous measurement trigger may be a setting programmed into the controller 18, where the controller 18 is configured to calculate the NRD for the patient P at regular intervals. By way of example and not limitation, the controller 18 may be configured to take an NRD measurement at least two hours after the previous NRD measurement and no more than four hours after the previous NRD measurement. The get vitals trigger may be a setting programmed into the controller 18 where the controller 18 determines the NRD of the patient P when one or more other vital signs being measured by the EWS system or by the optional sensors 22 of the NRD monitoring system 10 reach a certain value. By way of example and not limitation, if one of the optional sensors 22 included in the NRD monitoring system 10 is an SpO2 sensor, the get vitals setting may be configured to trigger the controller 18 to calculate the NRD index when the SpO2 of the patient P falls below a certain level. It will be appreciated that the triggers may be activated alone or in various combinations with each other as deemed appropriate by the caregiver, the patient P, or other appropriate party.When any of the trigger conditions are met, a specific alarm, e.g., an audio and / or visual alarm, issued through the user interface 20 and / or the caregiver prompts the patient P to perform a normal breathing task and a nose breathing task, thereby enabling the controller 18 to calculate the NRD index.

[0033]

[37] As discussed above with respect to the vital signs trigger of the trigger mode, data sensed by the optional non-EMG sensors 22 included in the NRD monitoring system 10, such as an accelerometer, a chest SpO2 sensor, or a core body temperature sensor, may be used to trigger the calculation of the NRD index. However, it should be noted that data sensed by the optional sensors 22 may also be used to switch the controller 18 between the trigger mode and the continuous mode. As discussed above, in the continuous mode, the controller 18 makes an absolute determination of NRD based only on normal breathing EMG signal data, without any nasal breathing EMG signal data. It will be appreciated that when the patient P is asleep, it is preferable to operate the controller 18 in the continuous mode rather than operating in the trigger mode. However, it will be appreciated that the continuous mode may be employed whether the patient P is asleep or awake. Either the accelerometer or the core body temperature sensor may be used to determine whether the patient P is asleep. Among other things, the accelerometer signal data can be used to determine the posture of the patient P, i.e., whether upright or lying down. Core body temperature is known to decrease during sleep and increase during wakefulness.

[0034]

[38] If the accelerometer data indicates that the patient P is lying down or if the core body temperature reading is relatively low, the patient P may be presumed to be asleep, especially if the patient P also exhibits a low heart rate and / or a low respiration rate. Based on any combination of the factors of sleeping position, low core body temperature, heart rate, and low respiration rate, the controller 18 may be configured to automatically switch from the trigger mode to operate in the continuous mode. Conversely, if the accelerometer data indicates that the patient P is now sitting up or moving around more than he / she was a short time ago, or if the core body temperature reading is relatively high and the heart rate and / or respiration rate are relatively high, the controller 18 may be configured to automatically switch from the continuous mode to operate in the trigger mode. The controller 18 is configured to calculate the NRD index based only on the normal breathing EMS signal data for the duration of the continuous mode of operation.

[0035]

[39] In another exemplary embodiment, the controller 18 may be configured to operate in an extended continuous mode. In this mode, the controller 18 operates similarly to the continuous mode, but additionally regularly monitors non-EMG respiratory data in addition to the NRD index. By way of example and not limitation, in the extended continuous mode, the controller 18 may be configured to measure heart rate, respiratory rate, and SpO2 every 30 minutes in addition to regularly monitoring the NRD index. As in the continuous mode, in the extended continuous mode, the controller 18 produces an absolute NRD index based only on normal breathing EMG signal data, rather than a relative NRD index based on both normal breathing EMG data and nasal breathing EMG data. Thus, like the continuous mode, the extended continuous mode is preferred over the triggered mode for a sleeping patient P. However, it will be appreciated that the extended continuous mode may also be employed while the patient P is awake. Both the continuous mode and the extended continuous mode may be collectively referred to as "continuous mode."

[0036]

[40] In an exemplary embodiment, the controller 18 may be configured to allow a user of the NRD monitoring system 10 (e.g., a caregiver or patient P) to manually initiate the calculation of the NRD index at a certain time, whether it is in the trigger mode or one of the continuous modes. It will be appreciated that a user manually initiating the NRD calculation may choose to initiate a relative NRD calculation that requires the patient P to perform a nasal breathing task, or an absolute NRD calculation that requires the patient P to only breathe normally. In addition, it should be noted that, whether the trigger mode is distinct from the continuous mode, in the trigger mode, the controller 18 may be configured to continuously monitor the absolute NRD using only normal breathing EMG data between triggered calculations of the relative NRD.

[0037]

[41] As mentioned above, the continuous mode may be employed whether the patient P is asleep or awake. Although it is generally preferred to employ the triggered mode when the patient P is awake due to the high accuracy of the relative NRD index based on both normal breathing EMG data and nasal breathing EMG data (as demonstrated by the ROC curve 30 in FIG. 4), there are circumstances in which it is preferable to use the continuous or extended continuous mode when the patient P is awake. In one non-limiting example, in a general ward of a hospital, the continuous or extended continuous mode is employed when monitoring of the NRD is desired between spot checks by a clinician, and when it is determined that it is undesirable for the patient P to breathe through the nose without the guidance of a clinician. Continuous or extended continuous mode NRD monitoring is also desired to avoid the "white coat effect," in which stress induced on the patient by the presence of a clinician affects the patient's vital signs. Although breathing through the nose may be difficult to do correctly without clinician supervision, if it is desired to obtain a relative NRD index in the absence of a clinician, the controller 18 may be configured to provide appropriate guidance to the patient P through the user interface 20 to ensure proper breathing through the nose. However, regardless of whether the controller 18 performs a relative or absolute determination of NRD, it is apparent that the inclusion of the NRD monitoring system and method disclosed herein in a non-invasive EWS system will clearly improve the accuracy of the determination of the patient's respiratory status.

[0038]

[42] In the claims, any reference signs placed in parentheses shall not be construed as limiting the claim. The word "comprises" or "including" does not exclude the presence of elements or steps other than those listed in the claim. In a device claim enumerating several means, several of these means may be embodied by one and the same item of hardware. The word "a" or "an" does not exclude the presence of a plurality of such elements. In any device claim enumerating several means, several of these means may be embodied by one and the same item of hardware. The mere fact that certain elements are recited in mutually different dependent claims does not indicate that these elements cannot be used in combination.

[0039]

[43] While the present invention has been described in detail for illustrative purposes based on what is presently considered to be the most practical and preferred embodiment, it should be understood that such detail is solely for the purposes of this application and that the present invention is not limited to the disclosed embodiment, but rather is intended to encompass modifications and equivalent arrangements that are within the spirit and scope of the appended claims. For example, it should be understood that the present invention contemplates that, to the extent possible, one or more features of any embodiment can be combined with one or more features of any other embodiment.

Claims

1. 1. A non-invasive patient monitoring system for non-invasively determining a patient's respiratory status and at least one other non-respiratory metric of said patient, said system comprising: a plurality of EMG electrodes structured to be affixed to the patient's upper chest; and Some non-EMG sensors A sensor patch comprising: a controller electrically connected to the EMG electrodes and the non-EMG sensors; a user interface in electrical communication with the controller; Equipped with the controller is configured to determine a neural respiratory drive index based on EMG signal data sensed by the EMG electrodes during at least one of a normal breathing action and a nasal inhalation action. system.

2. the plurality of EMG electrodes includes two signal electrodes and one reference electrode; the sensor patch is structured to be affixed to the patient's skin such that the two signal electrodes are both positioned in a second intercostal space of the patient and the reference electrode is positioned on the patient's sternum superior to the two signal electrodes. The system of claim 1 .

3. the controller is configured to determine normal breathing attributes of some of the EMG signal data sensed during normal breathing and snorting attributes of some of the EMG signal data sensed during the act of inhaling through the nose; the controller is configured to determine the neurorespiratory drive index by comparing the number of normal breathing attributes of the EMG signal data to the number of nasal breathing attributes of the EMG signal data. The system of claim 1 .

4. the controller is configured to determine certain normal breathing attributes of the EMG signal data sensed during normal breathing; the controller is configured to determine the neural respiratory drive index based solely on the some normal breathing attributes of the EMG signal data. The system of claim 1 .

5. the controller is configured to determine normal breathing attributes of some of the EMG signal data sensed during normal breathing and snorting attributes of some of the EMG signal data sensed during the act of inhaling through the nose; the controller is configured to determine a relative index of neural respiratory drive by comparing attributes of the number of normal breaths of the EMG signal data to attributes of the number of nasal breaths of the EMG signal data; the controller is configured to determine an absolute index of neural respiratory drive based solely on the some normal breathing attributes of the EMG signal data; the controller is configured to switch between a plurality of operating modes; In a first mode of the plurality of operational modes, the controller determines the relative index of neural respiratory drive; and in a second mode of the plurality of operational modes, the controller determines the absolute index of neural respiratory drive. The system of claim 1 .

6. the controller is configured to determine whether the patient is awake or asleep; the controller is configured to operate in the first mode when the patient is awake; the controller is configured to operate in the second mode when the patient is asleep. The system of claim 5.

7. the number of non-EMG sensors including at least one of an SpO2 sensor and a core body temperature sensor; the controller is configured to determine whether the patient is awake or asleep using data sensed by the number of non-EMG sensors; The system of claim 6.

8. 1. A method for non-invasively monitoring a patient's neural respiratory drive and at least one other non-respiratory metric, the method comprising: positioning a sensor patch comprising a number of EMG electrodes and a number of non-EMG sensors on the patient's upper chest; electrically connecting the sensor patch to a controller; sensing EMG signal data at a number of said EMG electrodes during an inhalation action performed by said patient; determining, with the controller, a neural respiratory drive index based on some attribute of the inhalation; having the act of inhaling includes at least one of taking a normal breath or inhaling through the nose; the step of electrically connecting the sensor patch to the controller electrically connecting the plurality of EMG electrodes and the number of non-EMG sensors to the controller. method.

9. The step of positioning a number of EMG electrodes comprises: positioning two signal EMG electrodes in a second intercostal space of the patient; placing a reference electrode on the patient's sternum above the two signal electrodes; having The method according to claim 8.

10. the determining the neurorespiratory drive index comprises at least one of determining a relative index of neurorespiratory drive and determining an absolute index of neurorespiratory drive; said determining said relative index of neural respiratory drive comprises comparing some normal breathing attributes of said EMG signal data sensed during normal breathing with some nasal breathing attributes of said EMG signal data sensed during the act of inhaling through the nose; said determining said absolute index of neural respiratory drive comprises determining only said some normal breathing attributes of said EMG signal data. The method according to claim 8.

11. and wherein the determining the neural respiratory drive index using the controller further comprises switching between a plurality of operational modes; In a first mode of the plurality of operational modes, the controller determines the relative index of neural respiratory drive; and in a second mode of the plurality of operational modes, the controller determines the absolute index of neural respiratory drive. The method of claim 10.

12. operating the controller in the first mode of operation when the patient is awake; operating the controller in the second mode of operation when the patient is asleep; The method of claim 11 further comprising:

13. 1. A non-invasive patient monitoring system for non-invasively determining a patient's respiratory status and at least one other non-respiratory metric of said patient, said system comprising: a sensor patch structured to be attached to the skin of the patient's upper chest, A plurality of EMG electrodes; Some non-EMG sensors, and A controller electrically connected to the sensor patch. A sensor patch comprising: a user interface in electrical communication with the controller; Equipped with the controller is configured to determine a neural respiratory drive index based on EMG signal data sensed by the EMG electrodes during at least one of a normal breathing action and a nasal inhalation action. system.

14. the plurality of EMG electrodes includes two signal electrodes and one reference electrode; the sensor patch is structured to be affixed to the skin of the patient such that both of the two signal electrodes are positioned in a second intercostal space of the patient and the reference electrode is positioned on the patient's sternum superior to the two signal electrodes. The system of claim 13.

15. The system of claim 13 , wherein the controller is configured to communicate data sensed by the sensor patch to a computing cloud.